Who are Lykon's investors?

Lykon's investors include Berliner Volksbank Ventures, Bridge to Growth, Caesar Ventures, Redstone, Tane Fund, Zintinus.

Lykon

Founded 2015 · 29 employees on LinkedIn · 6 known investors

Lykon offers at-home diagnostic self-tests (e.g. blood tests) that are analyzed in a lab to produce personalized nutrition recommendations and plans for goals like digestion, weight loss, and general wellbeing. It sells consumer health products in Germany combining nutritional medicine, behavior-change techniques, and digital tools.

Digital Health Direct to Consumer Wellness & Fitness

Investors · 6

Berliner Volksbank VenturesBerlin · $550K – $2.8M

Bridge to GrowthBerlin · $1.1M – $5.4M

Caesar VenturesMunich

RedstoneBerlin · $500K – $2.5M

Tane Fund$300K – $3M

ZintinusBoulder

Competitors · 1

by search overlap

Wyndly3 shared keywordsWyndly provides personalized allergy treatment through board-certified doctors, delivering clinical immunotherapy and testing directly to patients' homes without requiring office visits. The company serves individuals seeking modern, accessible allergy care with remote consultations and continuous physician support.

Companies competing with Lykon for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Lykon do?: Lykon offers at-home diagnostic self-tests (e.g. blood tests) that are analyzed in a lab to produce personalized nutrition recommendations and plans for goals like digestion, weight loss, and general wellbeing. It sells consumer health products in Germany combining nutritional medicine, behavior-change techniques, and digital tools.
Who are Lykon's investors?: Lykon's investors include Berliner Volksbank Ventures, Bridge to Growth, Caesar Ventures, Redstone, Tane Fund, Zintinus.